BiotechTube

valdecoxib + valdecoxib/placebo + placebo

Phase 3Completed
0 views this week 0 watching⚡ Active
Interest: 40/100
40
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Pain, Post-surgical

Conditions

Pain, Post-surgical

Trial Timeline

Dec 1, 2002 → Mar 1, 2003

NCT ID
NCT00653354

About valdecoxib + valdecoxib/placebo + placebo

valdecoxib + valdecoxib/placebo + placebo is a phase 3 stage product being developed by Pfizer for Pain, Post-surgical. The current trial status is completed. This product is registered under clinical trial identifier NCT00653354. Target conditions include Pain, Post-surgical.

What happened to similar drugs?

20 of 20 similar drugs in Pain, Post-surgical were approved

Approved (20) Terminated (4) Active (0)
✅Popliteal nerve block including liposomal bupivacaine + Adductor canal nerve block including liposomal bupivacaine + Continuous popliteal nerve block with normal saline + Popliteal nerve block with exclusively unencapsulated bupivacaine + Adductor canal nerve block with exclusively unencapsulated bupivacaine + Continuous popliteal nerve block with unencapsulated bupivacainePacira BiosciencesApproved
✅0.75% bupivacaine + .75% bupivacaine + .75% bupivacaineSI-BONEApproved
✅pregabalin sustained release tablet + pregabalin immediate release capsuleYuhanApproved
✅Topical High dose Capsaicin + Topical PlaceboAstellas PharmaApproved
✅Solifenacin succinate treatment + Oxycodone and acetaminophen combination treatmentAstellas PharmaApproved
✅Qutenza + PregabalinAstellas PharmaApproved
✅Duloxetine + Pregabalin + PlaceboShionogiApproved

Hype Score Breakdown

Clinical
17
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT00653354Phase 3Completed

Competing Products

20 competing products in Pain, Post-surgical

See all competitors
ProductCompanyStageHype Score
DFN-15 (Celecoxib Oral Solution) 62.5 mg + DFN-15 (Celecoxib Oral Solution) 125 mg + DFN-15 (Celecoxib Oral Solution) 250 mg + PlaceboDr. Reddy's LaboratoriesPhase 2
32
PRF110- oily solution (Ropivacaine)PainReformPhase 2
25
PRF110PainReformPhase 2
21
PRF-108 + Placebo + Ropivacaine + PRF-110PainReformPhase 1/2
22
TRV130 1.5 mg + TRV130 3 mg + TRV130 4.5 mg + Morphine 10 mg + PlaceboTrevenaPhase 1
19
Oliceridine + Placebo + MorphineTrevenaPhase 3
30
Oliceridine + Placebo + MorphineTrevenaPhase 3
30
TRV130TrevenaPhase 3
30
TRV130 + Morphine + PlaceboTrevenaPhase 2
25
TRV130TrevenaPhase 2
17
LY3556050 + PlaceboEli LillyPhase 2
35
Popliteal nerve block including liposomal bupivacaine + Adductor canal nerve block including liposomal bupivacaine + Continuous popliteal nerve block with normal saline + Popliteal nerve block with exclusively unencapsulated bupivacaine + Adductor canal nerve block with exclusively unencapsulated bupivacaine + Continuous popliteal nerve block with unencapsulated bupivacainePacira BiosciencesApproved
44
Nanoformed Piroxicam IR Tablet + Felden (piroxicam) Tablets + Brexidol (piroxicam) TabletsNanoform FinlandPhase 1
23
0.75% bupivacaine + .75% bupivacaine + .75% bupivacaineSI-BONEApproved
29
LY3526318 + PlaceboEli LillyPhase 2
35
LY3857210 + PlaceboEli LillyPhase 2
35
OK-101 0.05% + OK-101 0.1% + PlaceboOKYO PharmaPhase 2
17
YHD1119 + LyricaYuhanPhase 1
29
YHD1119 + LyricaYuhanPhase 1
29
YHD1119 + LyricaYuhanPhase 3
40